Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery

Study Identifier
AG9818-001
CT.gov Identifier
NCT00544713
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Dry Eye
    • Study Drug
  • Carboxymethylcellulose and Glycerin based artificial tear
  • Carboxymethylcellulose
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Candidate for bilateral LASIK surgery for myopia correction in the range of -1.00 to -8.00 diopters
    Exclusion Criteria:
    * Dry eye signs and symptoms * Preoperative soft or rigid contact lens wear within last 7 or 30 days, respectively * Pregnancy or planning pregnancy * Uncontrolled systemic disease * Use of systemic medications affecting dry eye

    Protocol Summary

    This study will evaluate the safety and efficacy of a new artificial tear for the treatment of dry eye that may occur after LASIK surgery

    Study Locations

    Location
    Status
    Location
    San Diego, California, United States
    Status
    Not applicable